Implementação do rastreio auditivo neonatal universal de surdez no Hospital CUF Porto

A incidência de perda auditiva bilateral é de 1 a 3 por cada recém-nascidos saudáveis e de 30 a 40 por 1000 recém-nascidos de risco. No Hospital Cuf Porto (HCP) o Rastreio Auditivo Neonatal Universal (RANU) teve inicio em Dezembro de 2010 em paralelo com abertura dos serviços de Obstetrícia / Neonatologia. As otoemissões acústicas (OEA) são o teste utilizado pois são reconhecidas como um método de rastreio auditivo simples, seguro e bem aceite. O objectivo deste trabalho é salientar a importância do RANU na identificação da perda auditiva antes da alta hospitalar, apresentando as suas vantagens na detecção e intervenção precoce minimizando as consequências da perda auditiva. Este trabalho, pretende ainda demonstrar as vantagens do RANU como estratégia fundamental no planeamento e na introdução de medidas de diagnóstico e terapêutica. É assim apresentada uma análise retrospectiva dos resultados obtidos nas OEA por produtos de distorção (OEAPD) entre Janeiro de 2011 e Dezembro de 2012, com uma amostra constituída por n=572. Os resultados revelam uma percentagem de “PASS” (OEAPD presentes) na primeira fase do rastreio, com um valor de 88,8% relativamente ao número total de rastreios efectuados. Relativamente à percentagem de “REFER” (OEAPD ausentes) – na mesma fase do rastreio- obtiveram-se 11,2% de situações face ao total de rastreados. Destes – que correspondem a um n=64 – 42.2% das situações referem-se a “REFER” bilateral (n=27). Relativamente às situações de “REFER” unilateral (n=37), encontramos uma percentagem de 57,8% dos casos. De acordo com a casuística apresentada, correspondente aos resultados obtidos e atendendo à realidade da população rastreada (dado que até ao momento não se confirmou perda auditiva em nenhum dos indivíduos rastreados), pode-se concluir que os OEA podem ser um método de rastreio simples e fiável, fundamental para a detecção e intervenção precoce nas perdas auditivas.

Nanotechnology and antioxidant therapy: An emerging approach for neurodegenerative diseases

The efficacy, cellular uptake and specific transport of dietary antioxidants to target organs, tissues and cells remains the most important setback for their application in the treatment of oxidative-stress related disorders and in particular in neurodegenerative diseases, as brain targeting remains a still unsolved challenge. Nanotechnology based delivery systems can be a solution for the above mentioned problems, specifically in the case of targeting dietary antioxidants with neuroprotective activity. Nanotechnology-based delivery systems can protect antioxidants from degradation, improve their physicochemical drug-like properties and in turn their bioavailability. The impact of nanomedicine in the improvement of the performance of dietary antioxidants, as protective agents in oxidative- stress events, specifically through the use of drug delivery systems, is highlighted in this review as well as the type of nanomaterials regularly used for drug delivery purposes. From the data one can conclude that the research combining (dietary) antioxidants and nanotechnology, namely as a therapeutic solution for neurodegenerative diseases, is still in a very early stage. So, a huge research area remains to be explored that hopefully will yield new and effective neuroprotective therapeutic agents in a foreseeable future.

Is There Sufficient Training of Health Care Staff on Noise Reduction in Neonatal Intensive Care Units? a Pilot Study From NeoNoise Project

Evidence indicates that exposure to high levels of noise adversely affects human health, and these effects are dependent upon various factors. In hospitals, there are many sources of noise, and high levels exert an impact on patients and staff, increasing both recovery time and stress, respectively. The goal of this pilot study was to develop, implement and evaluate the effectiveness of a training program (TP) on noise reduction in a Neonatal Intensive Care Units (NICU) by comparing the noise levels before and after the implementation of the program. A total of 79 health professionals participated in the study. The measurements of sound pressure levels took into account the layout of the unit and location of the main sources of noise. General results indicated that LAeq levels before implementation of the training program were often excessive, ranging from 48.7 ± 2.94 dBA to 71.7 ± 4.74 dBA, exceeding international guidelines. Similarly following implementation of the training program noise levels remained unchanged (54.5 ± 0.49 dBA to 63.9 ± 4.37 dBA), despite a decrease in some locations. There was no significant difference before and after the implementation of TP. However a significant difference was found for Lp, Cpeak, before and after training staff, suggesting greater care by healthcare professionals performing their tasks. Even recognizing that a TP is quite important to change behaviors, this needs to be considered in a broader context to effectively control noise in the NICU.

Disposable immunosensor using a simple method for oriented antibody immobilization for label-free real-time detection of an oxidative stress biomarker implicated in cancer diseases

This work proposes a novel approach for a suitable orientation of antibodies (Ab) on an immunosensing platform, applied here to the determination of 8-hydroxy-2′-deoxyguanosine (8OHdG), a biomarker of oxidative stress that has been associated to chronic diseases, such as cancer. The anti-8OHdG was bound to an amine modified gold support through its Fc region after activation of its carboxylic functions. Non-oriented approaches of Ab binding to the platform were tested in parallel, in order to show that the presented methodology favored Ab/Ag affinity and immunodetection of the antigen. The immunosensor design was evaluated by quartz-crystal microbalance with dissipation, atomic force microscopy, electrochemical impedance spectroscopy (EIS) and square-wave voltammetry. EIS was also a suitable technique to follow the analytical behavior of the device against 8OHdG. The affinity binding between 8OHdG and the antibody immobilized in the gold modified platform increased the charge transfer resistance across the electrochemical set-up. The observed behavior was linear from 0.02 to 7.0 ng/mL of 8OHdG concentrations. The interference from glucose, urea and creatinine was found negligible. An attempt of application to synthetic samples was also successfully conducted. Overall, the presented approach enabled the production of suitably oriented Abs over a gold platform by means of a much simpler process than other oriented-Ab binding approaches described in the literature, as far as we know, and was successful in terms of analytical features and sample application.